Glooko

company

About

Glooko offers a Software-as-a-Service (SaaS) application for Diabetes Management.

  • 101 - 250

Details

Last Funding Type
Series B
Last Funding Money Raised
$16.50M
Industries
Diabetes,Health Care,mHealth,Mobile Apps,SaaS,Software
Founded date
Nov 1, 2010
Number Of Employee
101 - 250
Operating Status
Active

Glooko is the universal diabetes platform that provides insights to improve outcomes for people with diabetes (PWDs) and their care teams. Glooko connects to the world’s most popular diabetes devices, major fitness and activity trackers and supplies personalized, timely patient information such as glucose level, food, insulin, medications, blood pressure, diet and weight data. Trusted by the world’s leaders in diabetes care, we are in over 7,000 clinical locations and used by over 1.5 million PWDs in 23 countries across 15 languages. Learn more by visiting www.glooko.com.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$81.50M
Glooko has raised a total of $81.50M in funding over 2 rounds. Their latest funding was raised on Mar 16, 2021 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 16, 2021 Series D $30M 1 Detail
Jun 27, 2017 Series C $35M 1 Detail
Mar 17, 2015 Series B $16.50M 1 Medtronic Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Glooko is funded by 2 investors. Novo Nordisk and Medtronic are the most recent investors.
Investor Name Lead Investor Funding Round
Novo Nordisk Series D
Medtronic Series C